Results 231 to 240 of about 102,229 (258)

Phosphodiesterase‐5 Inhibitors and Migraine

Headache: The Journal of Head and Face Pain, 2004
Evans, Randolph W, Kruuse, Christina Rostrup   +1 more
openaire   +4 more sources

The phosphodiesterase inhibitor ‘war’

BJU International, 2003
openaire   +2 more sources

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly  

Phosphodiesterases and Their Inhibitors

2014
Andrew Simon Bell, Spiros Liras
openaire   +2 more sources

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah   +2 more
exaly  

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

Nature Medicine, 2022
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly